Gong, Jifang
Peking University Cancer Hospital
3 papers on CoChatORCID 0000-0003-3798-7024
Most cited papers
- Verified
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Qi, C., Gong, J., Li, J., Liu, D., Qin, Y., Ge, S., Zhang, M., Peng, Z., Zhou, J., Cao, Y., et al. (2022) · Nature Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 604
- Verified
Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer
Zhuo, N., Liu, C., Zhang, Q., Li, J., Zhang, X., Gong, J., Lu, M., Peng, Z., Zhou, J., Wang, X., et al. (2022) · JAMA Network Open
Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies
Cited by 30
- Verified
Phase 1 study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with advanced solid tumors.
Liu, D., Gong, J., Liu, T., Li, K., Yin, X., Liu, Y., Wang, Y., Wang, L., Wang, W., Zhang, Y., et al. (2021) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free